Moderna
$192.57Change from previous close: −5.35%Absolute change: −$10.89
At a glance
- Revenue growth
- −39.93%
- 2025 vs 2024
- Net margin
- -145.2%
- 2024: -110.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 1,944 | 3,236 | 6,848 | 19,263 | 18,471 |
| Cost of revenue | 4,000 | 6,007 | 9,538 | 8,711 | 4,608 |
| Gross profit | -2,056 | -2,771 | -2,690 | 10,552 | 13,863 |
| Selling, general and administrative | 1,018 | 1,174 | 1,549 | 1,132 | 567 |
| Research and development | 3,132 | 4,543 | 4,845 | 3,295 | — |
| Operating income | -3,074 | -3,945 | -4,239 | 9,420 | 13,296 |
| EBIT | -3,074 | -3,945 | -4,239 | 9,420 | 13,296 |
| EBITDA | -2,859 | -3,756 | -3,618 | 9,768 | 13,528 |
| Interest expense | 10.0 | 24.0 | 38.0 | 29.0 | 17.0 |
| Pre-tax income | -2,768 | -3,607 | -3,942 | 9,575 | 13,285 |
| Income tax | 54.0 | -46.0 | 772 | 1,213 | 1,083 |
| Net income | -2,822 | -3,561 | -4,714 | 8,362 | 12,202 |
| Net income to common shareholders | -2,822 | -3,561 | -4,714 | 8,362 | 12,202 |
| Basic EPS | -7.25 | -9.27 | -12.34 | 21.22 | 30.28 |
| Diluted EPS | -7.25 | -9.27 | -12.34 | 20.12 | 28.29 |
| Average shares (basic) | 389 | 384 | 382 | 394 | 403 |
| Average shares (diluted) | 389 | 384 | 382 | 416 | 431 |